Eli Lilly Lowering Price of Zepbound
Hugely popular weight loss drugs known as GLP-1's are finally getting cheaper, well at least one is, and that's the case with Eli Lilly drug Zettbound.
More Videos
Rebuilding Wall Street on the Blockchain: Inside NANT Global Finance
NANT Global Finance CEO Mark Elenowitz shares how blockchain is transforming capital markets with integrated brokerage, exchange, and transfer services.
From AI Everywhere to LEGO’s Smart Brick: Inside CES 2026
From AI everywhere to LEGO’s Smart Brick, The Verge’s Sean Hollister breaks down which CES 2026 innovations are really game-changers—and which may be hype.
Go Fund Yourself: The Modern Blueprint for Vitality
Organic Gorilla provides clean, plant-powered performance supplements. Plus, learn about Sanctom Social- a social club built for conscious connection.
Meet the Company Powering America’s Autonomous Deliveries
Ali Kashani, CEO of Serve Robotics, explains how 2,000 AI-powered robots are transforming last-mile delivery across major U.S. cities.
Are Parents Ready for Skyrocketing Childcare in 2026?
Taylor Bowley, Economist at Bank of America, details why childcare costs outpacing inflation may force tough financial trade-offs for U.S. families.
How Venezuela’s Oil Comeback Could Rewrite U.S. Energy Independence
Jay Hatfield, CEO/CIO of Infrastructure Capital Advisors, weighs in on how heavy crude may reshape U.S. refineries and energy equities.
How Retail Investors May Be Rewriting the Rules of the Market
As markets hit record highs amid volatility, eToro U.S. Head Andrew McCormick breaks down how retail investor behavior is rapidly evolving.
Exclusive: Robin Williams' Son Talks Using AI to Bring Precision to Mental Health Care
Zak Williams discusses Lumos AI and how it uses longitudinal data to match the right mental health treatment to patients sooner.
